Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2011

Open Access 01-12-2011 | Research article

How to handle mortality when investigating length of hospital stay and time to clinical stability

Authors: Guy N Brock, Christopher Barnes, Julio A Ramirez, John Myers

Published in: BMC Medical Research Methodology | Issue 1/2011

Login to get access

Abstract

Background

Hospital length of stay (LOS) and time for a patient to reach clinical stability (TCS) have increasingly become important outcomes when investigating ways in which to combat Community Acquired Pneumonia (CAP). Difficulties arise when deciding how to handle in-hospital mortality. Ad-hoc approaches that are commonly used to handle time to event outcomes with mortality can give disparate results and provide conflicting conclusions based on the same data. To ensure compatibility among studies investigating these outcomes, this type of data should be handled in a consistent and appropriate fashion.

Methods

Using both simulated data and data from the international Community Acquired Pneumonia Organization (CAPO) database, we evaluate two ad-hoc approaches for handling mortality when estimating the probability of hospital discharge and clinical stability: 1) restricting analysis to those patients who lived, and 2) assigning individuals who die the "worst" outcome (right-censoring them at the longest recorded LOS or TCS). Estimated probability distributions based on these approaches are compared with right-censoring the individuals who died at time of death (the complement of the Kaplan-Meier (KM) estimator), and treating death as a competing risk (the cumulative incidence estimator). Tests for differences in probability distributions based on the four methods are also contrasted.

Results

The two ad-hoc approaches give different estimates of the probability of discharge and clinical stability. Analysis restricted to patients who survived is conceptually problematic, as estimation is conditioned on events that happen at a future time. Estimation based on assigning those patients who died the worst outcome (longest LOS and TCS) coincides with the complement of the KM estimator based on the subdistribution hazard, which has been previously shown to be equivalent to the cumulative incidence estimator. However, in either case the time to in-hospital mortality is ignored, preventing simultaneous assessment of patient mortality in addition to LOS and/or TCS. The power to detect differences in underlying hazards of discharge between patient populations differs for test statistics based on the four approaches, and depends on the underlying hazard ratio of mortality between the patient groups.

Conclusions

Treating death as a competing risk gives estimators which address the clinical questions of interest, and allows for simultaneous modelling of both in-hospital mortality and TCS / LOS. This article advocates treating mortality as a competing risk when investigating other time related outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol. 2006, 27 (5): 493-9. 10.1086/503375.CrossRefPubMed Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol. 2006, 27 (5): 493-9. 10.1086/503375.CrossRefPubMed
2.
go back to reference Arnold F, LaJoie A, Marrie T, Rossi P, Blasi F, Luna C, Fernandez P, Porras J, Weiss K, Feldman C, Rodriguez E, Levy G, Arteta F, Roig J, Rello J, Ramirez J: The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2006, 10 (7): 739-43.PubMed Arnold F, LaJoie A, Marrie T, Rossi P, Blasi F, Luna C, Fernandez P, Porras J, Weiss K, Feldman C, Rodriguez E, Levy G, Arteta F, Roig J, Rello J, Ramirez J: The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2006, 10 (7): 739-43.PubMed
3.
go back to reference Arnold FW, Brock GN, Peyrani P, Rodriguez EL, Diaz AA, Rossi P, Ramirez JA: Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med. 2010, 104 (11): 1736-43. 10.1016/j.rmed.2010.05.022.CrossRefPubMed Arnold FW, Brock GN, Peyrani P, Rodriguez EL, Diaz AA, Rossi P, Ramirez JA: Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med. 2010, 104 (11): 1736-43. 10.1016/j.rmed.2010.05.022.CrossRefPubMed
4.
go back to reference Fishbane S, Niederman MS, Daly C, Magin A, Kawabata M, de Corla-Souza A, Choudhery I, Brody G, Gaffney M, Pollack S, Parker S: The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Arch Intern Med. 2007, 167 (15): 1664-9. 10.1001/archinte.167.15.1664.CrossRefPubMed Fishbane S, Niederman MS, Daly C, Magin A, Kawabata M, de Corla-Souza A, Choudhery I, Brody G, Gaffney M, Pollack S, Parker S: The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Arch Intern Med. 2007, 167 (15): 1664-9. 10.1001/archinte.167.15.1664.CrossRefPubMed
5.
go back to reference Menendez R, Torres A, Rodriguez de Castro F, Zalacain R, Aspa J, Martin Villasclaras JJ, Borderias L, Benitez Moya JM, Ruiz-Manzano J, Blanquer J, Perez D, Puzo C, Sanchez-Gascon F, Gallardo J, Alvarez CJ, Molinos L: Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004, 39 (12): 1783-90. 10.1086/426028.CrossRefPubMed Menendez R, Torres A, Rodriguez de Castro F, Zalacain R, Aspa J, Martin Villasclaras JJ, Borderias L, Benitez Moya JM, Ruiz-Manzano J, Blanquer J, Perez D, Puzo C, Sanchez-Gascon F, Gallardo J, Alvarez CJ, Molinos L: Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004, 39 (12): 1783-90. 10.1086/426028.CrossRefPubMed
6.
go back to reference Silber SH, Garrett C, Singh R, Sweeney A, Rosenberg C, Parachiv D, Okafo T: Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest. 2003, 124 (5): 1798-804. 10.1378/chest.124.5.1798.CrossRefPubMed Silber SH, Garrett C, Singh R, Sweeney A, Rosenberg C, Parachiv D, Okafo T: Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest. 2003, 124 (5): 1798-804. 10.1378/chest.124.5.1798.CrossRefPubMed
7.
go back to reference Bordon J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramirez J: The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest. 2008, 133 (3): 618-24. 10.1378/chest.07-1322.CrossRefPubMed Bordon J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramirez J: The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest. 2008, 133 (3): 618-24. 10.1378/chest.07-1322.CrossRefPubMed
8.
go back to reference Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y: Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone. Intern Med. 2008, 47 (21): 1865-74. 10.2169/internalmedicine.47.1343.CrossRefPubMed Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y: Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone. Intern Med. 2008, 47 (21): 1865-74. 10.2169/internalmedicine.47.1343.CrossRefPubMed
9.
go back to reference Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. 2002, New Jersey: Wiley-Interscience, 2CrossRef Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. 2002, New Jersey: Wiley-Interscience, 2CrossRef
10.
go back to reference Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J: Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011, 11: 86-10.1186/1471-2288-11-86.CrossRefPubMedPubMedCentral Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J: Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011, 11: 86-10.1186/1471-2288-11-86.CrossRefPubMedPubMedCentral
11.
go back to reference Klein J, Rizzo J, Zhang MJ, Keiding N: Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001, 28: 909-915. 10.1038/sj.bmt.1703260.CrossRefPubMed Klein J, Rizzo J, Zhang MJ, Keiding N: Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001, 28: 909-915. 10.1038/sj.bmt.1703260.CrossRefPubMed
12.
go back to reference Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M: Application of multistate models in hospital epidemiology: advances and challenges. Biom J. 2011, 53 (2): 332-50. 10.1002/bimj.201000146.CrossRefPubMed Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M: Application of multistate models in hospital epidemiology: advances and challenges. Biom J. 2011, 53 (2): 332-50. 10.1002/bimj.201000146.CrossRefPubMed
13.
go back to reference Allignol A, Schumacher M, Beyersmann J: A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data. Biom J. 2010, 52: 126-37. 10.1002/bimj.200900039.CrossRefPubMed Allignol A, Schumacher M, Beyersmann J: A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data. Biom J. 2010, 52: 126-37. 10.1002/bimj.200900039.CrossRefPubMed
14.
go back to reference Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007, 26 (11): 2389-430. 10.1002/sim.2712.CrossRefPubMed Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007, 26 (11): 2389-430. 10.1002/sim.2712.CrossRefPubMed
15.
go back to reference Gray R: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988, 16: 1141-1154. 10.1214/aos/1176350951.CrossRef Gray R: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988, 16: 1141-1154. 10.1214/aos/1176350951.CrossRef
16.
go back to reference Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999, 94 (446): 496-509. 10.2307/2670170.CrossRef Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999, 94 (446): 496-509. 10.2307/2670170.CrossRef
18.
go back to reference Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menendez R, Lopardo G, Torres A, Rossi P, Ramirez JA: Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med. 2009, 169 (16): 1515-24. 10.1001/archinternmed.2009.265.CrossRefPubMed Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menendez R, Lopardo G, Torres A, Rossi P, Ramirez JA: Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med. 2009, 169 (16): 1515-24. 10.1001/archinternmed.2009.265.CrossRefPubMed
19.
go back to reference Volk ML, Reichert HA, Lok AS, Hayward RA: Variation in Organ Quality between Liver Transplant Centers. Am J Transplant. 2011, 11 (5): 958-64. 10.1111/j.1600-6143.2011.03487.x.CrossRefPubMedPubMedCentral Volk ML, Reichert HA, Lok AS, Hayward RA: Variation in Organ Quality between Liver Transplant Centers. Am J Transplant. 2011, 11 (5): 958-64. 10.1111/j.1600-6143.2011.03487.x.CrossRefPubMedPubMedCentral
20.
go back to reference Klein JP, Moeschberger ML: Survival analysis: techniques for censored and truncated data. 2003, New York: Springer-Verlag, 2 Klein JP, Moeschberger ML: Survival analysis: techniques for censored and truncated data. 2003, New York: Springer-Verlag, 2
21.
go back to reference Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: :457-481. 10.2307/2281868.CrossRef Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: :457-481. 10.2307/2281868.CrossRef
22.
go back to reference Aalen O, Johansen S: An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978, 5: 141-150. Aalen O, Johansen S: An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978, 5: 141-150.
23.
go back to reference Braun TM, Yuan Z: Comparing the small sample performance of several variance estimators under competing risks. Stat Med. 2007, 26 (5): 1170-80. 10.1002/sim.2661.CrossRefPubMed Braun TM, Yuan Z: Comparing the small sample performance of several variance estimators under competing risks. Stat Med. 2007, 26 (5): 1170-80. 10.1002/sim.2661.CrossRefPubMed
25.
go back to reference Geskus RB: Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011, 67: 39-49. 10.1111/j.1541-0420.2010.01420.x.CrossRefPubMed Geskus RB: Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011, 67: 39-49. 10.1111/j.1541-0420.2010.01420.x.CrossRefPubMed
26.
go back to reference Zhang X, Zhang MJ, Fine JP: A mass redistribution algorithm for right-censored and left-truncated time to event data. J Stat Plan Infer. 2009 Zhang X, Zhang MJ, Fine JP: A mass redistribution algorithm for right-censored and left-truncated time to event data. J Stat Plan Infer. 2009
27.
go back to reference Breslow NE: Analysis of survival data under the proportional hazards model. International Statistics Review. 1975, 43: 45-58. 10.2307/1402659.CrossRef Breslow NE: Analysis of survival data under the proportional hazards model. International Statistics Review. 1975, 43: 45-58. 10.2307/1402659.CrossRef
28.
go back to reference Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File JTM, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA: A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007, 175 (10): 1086-93. 10.1164/rccm.200603-350OC.CrossRefPubMed Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File JTM, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA: A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007, 175 (10): 1086-93. 10.1164/rccm.200603-350OC.CrossRefPubMed
29.
go back to reference Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001, 163 (7): 1730-54.CrossRefPubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001, 163 (7): 1730-54.CrossRefPubMed
30.
go back to reference Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997, 336 (4): 243-50. 10.1056/NEJM199701233360402.CrossRefPubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997, 336 (4): 243-50. 10.1056/NEJM199701233360402.CrossRefPubMed
31.
go back to reference Beyersmann J, Latouche A, Buchholz A, Schumacher M: Simulating competing risks data in survival analysis. Stat Med. 2009, 28 (6): 956-71. 10.1002/sim.3516.CrossRefPubMed Beyersmann J, Latouche A, Buchholz A, Schumacher M: Simulating competing risks data in survival analysis. Stat Med. 2009, 28 (6): 956-71. 10.1002/sim.3516.CrossRefPubMed
32.
33.
go back to reference Scrucca L, Santucci A, Aversa F: Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007, 40 (4): 381-7. 10.1038/sj.bmt.1705727.CrossRefPubMed Scrucca L, Santucci A, Aversa F: Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007, 40 (4): 381-7. 10.1038/sj.bmt.1705727.CrossRefPubMed
34.
go back to reference Allignol A, Schumacher M, Beyersmann J: Empirical transition matrix of multi-state models: the etm package. J Stat Softw. 2011, 38: Allignol A, Schumacher M, Beyersmann J: Empirical transition matrix of multi-state models: the etm package. J Stat Softw. 2011, 38:
36.
go back to reference de Wreede LC, Fiocco M, Putter H: mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011, 38: de Wreede LC, Fiocco M, Putter H: mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011, 38:
38.
go back to reference Efron B: The two sample problem with censored data. Proceedings of the fifth Berkeley Symposium, Vol 4. 1967, Berkeley, CA: University of California Press, 831-853. Efron B: The two sample problem with censored data. Proceedings of the fifth Berkeley Symposium, Vol 4. 1967, Berkeley, CA: University of California Press, 831-853.
39.
go back to reference Satten GA, Datta S: Kaplan-Meier representation of competing risk estimates. Stat Probabil Lett. 1999, 42: :299-304. 10.1016/S0167-7152(98)00220-X.CrossRef Satten GA, Datta S: Kaplan-Meier representation of competing risk estimates. Stat Probabil Lett. 1999, 42: :299-304. 10.1016/S0167-7152(98)00220-X.CrossRef
40.
go back to reference Datta S, Satten GA, Datta S: Nonparametric estimation for the three-stage irreversible illness-death model. Biometrics. 2000, 56 (3): 841-7. 10.1111/j.0006-341X.2000.00841.x.CrossRefPubMed Datta S, Satten GA, Datta S: Nonparametric estimation for the three-stage irreversible illness-death model. Biometrics. 2000, 56 (3): 841-7. 10.1111/j.0006-341X.2000.00841.x.CrossRefPubMed
41.
go back to reference Lan L, Datta S: Non-parametric estimation of state occupation, entry and exit times with multistate current status data. Stat Methods Med Res. 2010, 19 (2): 147-65. 10.1177/0962280208094278.CrossRefPubMed Lan L, Datta S: Non-parametric estimation of state occupation, entry and exit times with multistate current status data. Stat Methods Med Res. 2010, 19 (2): 147-65. 10.1177/0962280208094278.CrossRefPubMed
42.
go back to reference Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med. 1993, 12 (8): 737-51. 10.1002/sim.4780120803.CrossRefPubMed Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med. 1993, 12 (8): 737-51. 10.1002/sim.4780120803.CrossRefPubMed
43.
go back to reference Bentzen SM, Vaeth M, Pedersen DE, Overgaard J: Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!. Int J Radiat Oncol Biol Phys. 1995, 32 (5): 1531-4. 10.1016/0360-3016(95)00262-W.CrossRefPubMed Bentzen SM, Vaeth M, Pedersen DE, Overgaard J: Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!. Int J Radiat Oncol Biol Phys. 1995, 32 (5): 1531-4. 10.1016/0360-3016(95)00262-W.CrossRefPubMed
44.
go back to reference Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Transmission-associated nosocomial infections: prolongation of intensive care unit stay and risk factor analysis using multistate models. Am J Infect Control. 2008, 36 (2): 98-103. 10.1016/j.ajic.2007.06.007.CrossRefPubMed Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Transmission-associated nosocomial infections: prolongation of intensive care unit stay and risk factor analysis using multistate models. Am J Infect Control. 2008, 36 (2): 98-103. 10.1016/j.ajic.2007.06.007.CrossRefPubMed
45.
go back to reference Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M: Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med. 2009, 35 (5): 826-32. 10.1007/s00134-009-1423-6.CrossRefPubMed Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M: Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med. 2009, 35 (5): 826-32. 10.1007/s00134-009-1423-6.CrossRefPubMed
47.
go back to reference Rubin DB: Causal inference through potential outcomes and principal stratification: application to studies with "censoring" due to death. Statistical Science. 2006, 21 (3): 299-309. 10.1214/088342306000000114.CrossRef Rubin DB: Causal inference through potential outcomes and principal stratification: application to studies with "censoring" due to death. Statistical Science. 2006, 21 (3): 299-309. 10.1214/088342306000000114.CrossRef
48.
go back to reference Zhang JL, Rubin DB, Mealli F: Using the EM algorithm to estimate the effects of job training programs on wages. 55th Session of the International Statistical Institute. 2005 Zhang JL, Rubin DB, Mealli F: Using the EM algorithm to estimate the effects of job training programs on wages. 55th Session of the International Statistical Institute. 2005
49.
go back to reference Zhang JL, Rubin DB, Mealli F: Evaluating the effects of training programs on wages through principal stratification. Modelling and Evaluating Treatment Effects in Econometrics. Edited by: Millimet D, Smith J, Vytlacil E. 2008, Amsterdam: Elsevier Zhang JL, Rubin DB, Mealli F: Evaluating the effects of training programs on wages through principal stratification. Modelling and Evaluating Treatment Effects in Econometrics. Edited by: Millimet D, Smith J, Vytlacil E. 2008, Amsterdam: Elsevier
50.
go back to reference Cox D: Regression models and life-tables (with discussion). J Roy Stat Soc. 1972, B34: 187-220. Cox D: Regression models and life-tables (with discussion). J Roy Stat Soc. 1972, B34: 187-220.
51.
go back to reference Klein JP: Modelling competing risks in cancer studies. Stat Med. 2006, 25 (6): 1015-34. 10.1002/sim.2246.CrossRefPubMed Klein JP: Modelling competing risks in cancer studies. Stat Med. 2006, 25 (6): 1015-34. 10.1002/sim.2246.CrossRefPubMed
52.
go back to reference Grambauer N, Schumacher M, Beyersmann J: Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Stat Med. 2010, 29 (7-8): 875-84. 10.1002/sim.3786.CrossRefPubMed Grambauer N, Schumacher M, Beyersmann J: Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Stat Med. 2010, 29 (7-8): 875-84. 10.1002/sim.3786.CrossRefPubMed
53.
go back to reference Latouche A, Boisson V, Chevret S, Porcher R: Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med. 2007, 26 (5): 965-74. 10.1002/sim.2600.CrossRefPubMed Latouche A, Boisson V, Chevret S, Porcher R: Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med. 2007, 26 (5): 965-74. 10.1002/sim.2600.CrossRefPubMed
Metadata
Title
How to handle mortality when investigating length of hospital stay and time to clinical stability
Authors
Guy N Brock
Christopher Barnes
Julio A Ramirez
John Myers
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2011
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-11-144

Other articles of this Issue 1/2011

BMC Medical Research Methodology 1/2011 Go to the issue